Fundz

Blue Lake Biotechnology reported raising $10 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATENov 08, 2022Late filing, first sale Apr 9, 2022

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Apr 9, 2022)

Round Type

Venture

AthensBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Blue Lake Biotechnology that raised within 45 days of this round, from Fundz verified event records.

  • Kriya Therapeutics raised $271M on May 24, 2022.
  • Alithea Genomics raised an undisclosed amount (Seed) on May 24, 2022.
  • Pendulum raised an undisclosed amount (Corporate Round) on May 24, 2022.
  • Alida Biosciences Inc. raised $4M (Seed) on May 23, 2022.
  • Alphyn Biologics raised $2.2M (Seed) on May 23, 2022.
  • InflammX Therapeutics, Inc. raised an undisclosed amount on May 23, 2022.

Who to call at Blue Lake Biotechnology, and when

A new round usually means Blue Lake Biotechnology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Blue Lake Biotechnology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Blue Lake Biotechnology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Blue Lake Biotechnology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Blue Lake Biotechnology

Location

Athens, Georgia, United States

About

Our proprietary vaccines are based on parainfluenza virus 5 (PIV5), also known as canine parainfluenza virus. We insert a gene encoding an antigen of interest into the PIV5 genome. When one of our vaccine vectors is introduced to a host, it undergoes several rounds of self-limited replication, inducing robust immune responses with a single dose.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Blue Lake Biotechnology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Blue Lake Biotechnology's next move

See what Strategic adds

Blue Lake Biotechnology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.